195 related articles for article (PubMed ID: 30357519)
1. Challenging the heterogeneity of disease presentation in malignant melanoma-impact on patient treatment.
Marcell Szasz A; Malm J; Rezeli M; Sugihara Y; Betancourt LH; Rivas D; Gyorffy B; Marko-Varga G
Cell Biol Toxicol; 2019 Feb; 35(1):1-14. PubMed ID: 30357519
[TBL] [Abstract][Full Text] [Related]
2. Clinical protein science in translational medicine targeting malignant melanoma.
Gil J; Betancourt LH; Pla I; Sanchez A; Appelqvist R; Miliotis T; Kuras M; Oskolas H; Kim Y; Horvath Z; Eriksson J; Berge E; Burestedt E; Jönsson G; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Horvatovich P; Murillo JR; Sugihara Y; Welinder C; Wieslander E; Lee B; Lindberg H; Pawłowski K; Kwon HJ; Doma V; Timar J; Karpati S; Szasz AM; Németh IB; Nishimura T; Corthals G; Rezeli M; Knudsen B; Malm J; Marko-Varga G
Cell Biol Toxicol; 2019 Aug; 35(4):293-332. PubMed ID: 30900145
[TBL] [Abstract][Full Text] [Related]
3. Novel functional proteins coded by the human genome discovered in metastases of melanoma patients.
Sanchez A; Kuras M; Murillo JR; Pla I; Pawlowski K; Szasz AM; Gil J; Nogueira FCS; Perez-Riverol Y; Eriksson J; Appelqvist R; Miliotis T; Kim Y; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Ekedahl H; Horvatovich P; Sugihara Y; Welinder C; Wieslander E; Kwon HJ; Domont GB; Malm J; Rezeli M; Betancourt LH; Marko-Varga G
Cell Biol Toxicol; 2020 Jun; 36(3):261-272. PubMed ID: 31599373
[TBL] [Abstract][Full Text] [Related]
4. The human melanoma proteome atlas-Defining the molecular pathology.
Betancourt LH; Gil J; Kim Y; Doma V; Çakır U; Sanchez A; Murillo JR; Kuras M; Parada IP; Sugihara Y; Appelqvist R; Wieslander E; Welinder C; Velasquez E; de Almeida NP; Woldmar N; Marko-Varga M; Pawłowski K; Eriksson J; Szeitz B; Baldetorp B; Ingvar C; Olsson H; Lundgren L; Lindberg H; Oskolas H; Lee B; Berge E; Sjögren M; Eriksson C; Kim D; Kwon HJ; Knudsen B; Rezeli M; Hong R; Horvatovich P; Miliotis T; Nishimura T; Kato H; Steinfelder E; Oppermann M; Miller K; Florindi F; Zhou Q; Domont GB; Pizzatti L; Nogueira FCS; Horvath P; Szadai L; Tímár J; Kárpáti S; Szász AM; Malm J; Fenyö D; Ekedahl H; Németh IB; Marko-Varga G
Clin Transl Med; 2021 Jul; 11(7):e473. PubMed ID: 34323403
[TBL] [Abstract][Full Text] [Related]
5. Feasibility study on measuring selected proteins in malignant melanoma tissue by SRM quantification.
Welinder C; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Breslin T; Rezeli M; Jansson B; Laurell T; Fehniger TE; Wieslander E; Pawlowski K; Marko-Varga G
J Proteome Res; 2014 Mar; 13(3):1315-26. PubMed ID: 24490776
[TBL] [Abstract][Full Text] [Related]
6. Establishing a Southern Swedish Malignant Melanoma OMICS and biobank clinical capability.
Welinder C; Jönsson G; Ingvar C; Lundgren L; Olsson H; Breslin T; Végvári A; Laurell T; Rezeli M; Jansson B; Baldetorp B; Marko-Varga G
Clin Transl Med; 2013 Feb; 2(1):7. PubMed ID: 23445834
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of melanoma heterogeneity.
Hachey SJ; Boiko AD
Exp Dermatol; 2016 Jul; 25(7):497-500. PubMed ID: 27060971
[TBL] [Abstract][Full Text] [Related]
8. Correlation of histopathologic characteristics to protein expression and function in malignant melanoma.
Welinder C; Pawłowski K; Szasz AM; Yakovleva M; Sugihara Y; Malm J; Jönsson G; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Rezeli M; Laurell T; Wieslander E; Marko-Varga G
PLoS One; 2017; 12(4):e0176167. PubMed ID: 28445515
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers in Melanoma: Lessons from Translational Medicine.
Buchbinder EI; Flaherty KT
Trends Cancer; 2016 Jun; 2(6):305-312. PubMed ID: 28741528
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in melanoma research via "omics" platforms.
Rodríguez-Cerdeira C; Molares-Vila A; Carnero-Gregorio M; Corbalán-Rivas A
J Proteomics; 2018 Sep; 188():152-166. PubMed ID: 29138111
[TBL] [Abstract][Full Text] [Related]
11. Biobank integration of large-scale clinical and histopathology melanoma studies within the European Cancer Moonshot Lund Center.
Malm J; Sugihara Y; Szasz M; Kwon HJ; Lindberg H; Appelqvist R; Marko-Varga G
Clin Transl Med; 2018 Aug; 7(1):28. PubMed ID: 30123920
[TBL] [Abstract][Full Text] [Related]
12. Current status and future direction in the management of malignant melanoma.
Gladfelter P; Darwish NHE; Mousa SA
Melanoma Res; 2017 Oct; 27(5):403-410. PubMed ID: 28800028
[TBL] [Abstract][Full Text] [Related]
13. Markers and tissue resources for melanoma: meeting report.
Becker D; Mihm MC; Hewitt SM; Sondak VK; Fountain JW; Thurin M
Cancer Res; 2006 Nov; 66(22):10652-7. PubMed ID: 17108101
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling in melanoma: past results and future potential.
Knackstedt RW; Knackstedt T; Gastman B
Future Oncol; 2019 Mar; 15(7):791-800. PubMed ID: 30453756
[TBL] [Abstract][Full Text] [Related]
15. Detecting post-translational modification signatures as potential biomarkers in clinical mass spectrometry.
Mnatsakanyan R; Shema G; Basik M; Batist G; Borchers CH; Sickmann A; Zahedi RP
Expert Rev Proteomics; 2018 Jun; 15(6):515-535. PubMed ID: 29893147
[TBL] [Abstract][Full Text] [Related]
16. Systematic biobanking, novel imaging techniques, and advanced molecular analysis for precise tumor diagnosis and therapy: The Polish MOBIT project.
Niklinski J; Kretowski A; Moniuszko M; Reszec J; Michalska-Falkowska A; Niemira M; Ciborowski M; Charkiewicz R; Jurgilewicz D; Kozlowski M; Ramlau R; Piwkowski C; Kwasniewski M; Kaczmarek M; Ciereszko A; Wasniewski T; Mroz R; Naumnik W; Sierko E; Paczkowska M; Kisluk J; Sulewska A; Cybulski A; Mariak Z; Kedra B; Szamatowicz J; Kurzawa P; Minarowski L; Charkiewicz AE; Mroczko B; Malyszko J; Manegold C; Pilz L; Allgayer H; Abba ML; Juhl H; Koch F;
Adv Med Sci; 2017 Sep; 62(2):405-413. PubMed ID: 28646744
[TBL] [Abstract][Full Text] [Related]
17. Analysis of alpha-synuclein in malignant melanoma - development of a SRM quantification assay.
Welinder C; Jönsson GB; Ingvar C; Lundgren L; Baldetorp B; Olsson H; Breslin T; Rezeli M; Jansson B; Fehniger TE; Laurell T; Wieslander E; Pawlowski K; Marko-Varga G
PLoS One; 2014; 9(10):e110804. PubMed ID: 25333933
[TBL] [Abstract][Full Text] [Related]
18. Expanding the understanding of the heterogeneous nature of melanoma with bioinformatics and disorder-based proteomics.
Djulbegovic MB; Uversky VN
Int J Biol Macromol; 2020 May; 150():1281-1293. PubMed ID: 31743721
[TBL] [Abstract][Full Text] [Related]
19. Emerging Biomarkers in Cutaneous Melanoma.
Eisenstein A; Gonzalez EC; Raghunathan R; Xu X; Wu M; McLean EO; McGee J; Ryu B; Alani RM
Mol Diagn Ther; 2018 Apr; 22(2):203-218. PubMed ID: 29411301
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
